[CH3:1][N:2]1[C:6]([CH:7]2[O:14][C:11]3([CH2:13][CH2:12]3)[CH2:10][CH:9]([CH3:15])[O:8]2)=[C:5]([N+:16]([O-:18])=[O:17])[CH:4]=[N:3]1.C(=O)([O-])[O-].[Na+].[Na+].C([O-])(O)=O.[Na+]>C(Cl)Cl.[Ti](Cl)(Cl)(Cl)Cl>[CH3:15][CH:9]1[CH2:10][C:11](=[O:14])[CH2:13][CH2:12][CH:7]([C:6]2[N:2]([CH3:1])[N:3]=[CH:4][C:5]=2[N+:16]([O-:18])=[O:17])[O:8]1To a solution of 1-methyl-5-(5-methyl-6,8-dioxaspiro[2.5]octan-7-yl)-4-nitro-pyrazole (1.0 g, 3.95 mmol) in DCM (20 mL) at −78° C. was added titanium tetrachloride (6.6 mL, 59.3 mmol) dropwise. Halfway through the addition, the reaction mixture became harder to stir so more DCM (10 mL) was added. The brown slurry was warmed to 0° C. and stirred for 1 hr. Solid sodium carbonate (5 g) was cautiously added followed by saturated aqueous NaHCO3 (100 mL) and DCM (100 mL). The organic layer was washed with saturated aqueous NaHCO3, (100 mL) and brine (100 mL), separated, dried over Na2SO4 and concentrated under reduced pressure. Purification via silica gel column chromatography (0-100% EtOAc/isohexane) gave 2-methyl-7-(2-methyl-4-nitro-pyrazol-3-yl)oxepan-4-one as a colourless solid (749 mg, 75%). 1H NMR (400 MHz, CDCl3) δ 8.02 (s, 1H), 5.69 (dd, J=11.0, 2.4 Hz, 1H), 4.21-4.14 (m, 1H), 4.01 (s, 3H), 3.07-2.97 (m, 1H), 2.79-2.63 (m, 3H), 2.19-2.07 (m, 1H), 2.07-1.91 (m, 1H), 1.30 (d, J=6.2 Hz, 3H).